April, 2013: Pharma R&D and Biomarkers

PATHWAYS Newsletter

With the PATHWAYS newsletter, you can stay up to date with the latest news about Metabolon, explore abstracts from recent publication, and get industry insights from leading Metabolon experts.

This month's two feature stories are:

  • Overcoming Translational Barriers with Disruptive Technology, by Kirk Beebe, Director of Application Science for Metabolon.
  • A Proven Path for Metabolite Biomarker Discovery: A Technological Commentary, by Mike Milburn, Chief Scientific Officer for Metabolon.

No login or registration is required to view PATHWAYS.

Click here to download the newsletter.